- Device
- CRYSTALENS SE, MODEL AT-45 SE
- Applicant
- Bausch & Lomb, Inc.
- PMA number
- P030002
- Supplement
- S004
- Product code
- NAA
- Generic name
- Lens, intraocular, accommodative
- Decision date
- 2005-09-08
- Decision code
- APPR
- Date received
- 2005-07-05
- Supplement type
- Real-Time Process
- Supplement reason
- Labeling Change - Indications/instructions/shelf life/tradename
- Approval order statement
- APPROVAL FOR THE FOLLOWING MODIFICATIONS TO THE PHYSICIAN'S LABELING: CHANGE IN THE MODEL NUMBER AND TRADE NAME; CHANGE IN DIRECTIONS FOR USE TO FACILITATE PROPER INSERTION AND ORIENTATION OF THE LENS; AND, CHANGE IN THE EXISTING RECOMMENDATIONS FOR MAXIMIZING PATIENT OUTCOMES. THE DEVICE, AS MODIFIED, WILL BE MARKETED UNDER THE TRADE NAME CRYSTALENS SE (MODEL AT-45 SE) AND IS INDICATED FOR PRIMARY IMPLANTATION IN THE CAPSULAR BAG OF THE EYE FOR THE VISUAL CORRECTION OF APHAKIA SECONDARY TO THE REMOVAL OF A CATARACTOUS LENS IN ADULT PATIENTS WITH AND WITHOUT PRESBYOPIA. THE CRYSTALENS SE (MODEL AT-45 SE) PROVIDES APPROXIMATELY ONE DIOPTER OF MONOCULAR ACCOMMODATION WHICH ALLOWS FOR NEAR, INTERMEDIATE, AND DISTANCE VISION WITHOUT SPECTACLES.